185 related articles for article (PubMed ID: 27242341)
1. Dosimetric comparison of carbon ion and X-ray radiotherapy for Stage IIIA non-small cell lung cancer.
Kubo N; Saitoh JI; Shimada H; Shirai K; Kawamura H; Ohno T; Nakano T
J Radiat Res; 2016 Sep; 57(5):548-554. PubMed ID: 27242341
[TBL] [Abstract][Full Text] [Related]
2. Comparison of dose-volume histograms between proton beam and X-ray conformal radiotherapy for locally advanced non-small-cell lung cancer.
Ohno T; Oshiro Y; Mizumoto M; Numajiri H; Ishikawa H; Okumura T; Terunuma T; Sakae T; Sakurai H
J Radiat Res; 2015 Jan; 56(1):128-33. PubMed ID: 25368341
[TBL] [Abstract][Full Text] [Related]
3. A Dosimetric Comparative Study of Carbon-Ion Radiotherapy Versus X-ray Volumetric Modulated Arc Therapy for Stage III Non-Small-Cell Lung Cancer.
Li XJ; Li CR; Ye YC; Zhang YS; Zong XQ; Feng CL
Niger J Clin Pract; 2024 Feb; 27(2):236-243. PubMed ID: 38409153
[TBL] [Abstract][Full Text] [Related]
4. Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.
Hayashi K; Yamamoto N; Karube M; Nakajima M; Matsufuji N; Tsuji H; Ogawa K; Kamada T
Radiat Oncol; 2017 May; 12(1):91. PubMed ID: 28558766
[TBL] [Abstract][Full Text] [Related]
5. Intraindividual comparison of conventional three-dimensional radiotherapy and intensity modulated radiotherapy in the therapy of locally advanced non-small cell lung cancer a planning study.
Marnitz S; Stuschke M; Bohsung J; Moys A; Reng I; Wurm R; Budach V
Strahlenther Onkol; 2002 Nov; 178(11):651-8. PubMed ID: 12426677
[TBL] [Abstract][Full Text] [Related]
6. Late-Course Adaptive Adjustment Based on Metabolic Tumor Volume Changes during Radiotherapy May Reduce Radiation Toxicity in Patients with Non-Small Cell Lung Cancer.
Xiao L; Liu N; Zhang G; Zhang H; Gao S; Fu Z; Wang S; Yu Q; Yu J; Yuan S
PLoS One; 2017; 12(1):e0170901. PubMed ID: 28125698
[TBL] [Abstract][Full Text] [Related]
7. An in-silico comparison of proton beam and IMRT for postoperative radiotherapy in completely resected stage IIIA non-small cell lung cancer.
Berman AT; Teo BK; Dolney D; Swisher-McClure S; Shahnazi K; Both S; Rengan R
Radiat Oncol; 2013 Jun; 8():144. PubMed ID: 23767810
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric analysis between carbon ion radiotherapy and stereotactic body radiotherapy in stage I lung cancer.
Ebara T; Shimada H; Kawamura H; Shirai K; Saito J; Kawashima M; Tashiro M; Ohno T; Kanai T; Nakano T
Anticancer Res; 2014 Sep; 34(9):5099-104. PubMed ID: 25202098
[TBL] [Abstract][Full Text] [Related]
10. A Dose Escalation Clinical Trial of Single-Fraction Carbon Ion Radiotherapy for Peripheral Stage I Non-Small Cell Lung Cancer.
Yamamoto N; Miyamoto T; Nakajima M; Karube M; Hayashi K; Tsuji H; Tsujii H; Kamada T; Fujisawa T
J Thorac Oncol; 2017 Apr; 12(4):673-680. PubMed ID: 28007628
[TBL] [Abstract][Full Text] [Related]
11. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
van Der Wel A; Nijsten S; Hochstenbag M; Lamers R; Boersma L; Wanders R; Lutgens L; Zimny M; Bentzen SM; Wouters B; Lambin P; De Ruysscher D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):649-55. PubMed ID: 15708242
[TBL] [Abstract][Full Text] [Related]
12. [Are there any dosimetric advantages in using VMAT for treatment of locally advanced non-small cell lung cancer?].
Rousseau D; Autret D; Krhili S; Yossi S; Dupas A; Edouard M; Mahé MA; Giraud P; Le Péchoux C; Cellier P; Denis F; Paumier A
Cancer Radiother; 2012 Oct; 16(7):619-26. PubMed ID: 23089069
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric comparison and biological evaluation of PET- and CT-based target delineation for LA-NSCLC using auto-planning.
Shao Y; Wang H; Chen H; Gu H; Duan Y; Feng A; Li X; Xu Z
Phys Med; 2019 Nov; 67():77-84. PubMed ID: 31678800
[TBL] [Abstract][Full Text] [Related]
14. Adaptive carbon ion radiotherapy for locally advanced non-small cell lung cancer: Organ-sparing potential and target coverage.
Jia S; Chen J; Ma N; Zhao J; Mao J; Jiang G; Lu J; Wu K
Med Phys; 2022 Jun; 49(6):3980-3989. PubMed ID: 35192194
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric comparison between helical tomotherapy and intensity-modulated radiation therapy plans for non-small cell lung cancer.
Meng LL; Feng LC; Wang YL; Dai XK; Xie CB
Chin Med J (Engl); 2011 Jun; 124(11):1667-71. PubMed ID: 21740774
[TBL] [Abstract][Full Text] [Related]
16. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.
Chang JY; Zhang X; Wang X; Kang Y; Riley B; Bilton S; Mohan R; Komaki R; Cox JD
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1087-96. PubMed ID: 16682145
[TBL] [Abstract][Full Text] [Related]
17. Optimization of beam weights in conformal radiotherapy planning of stage III non-small cell lung cancer: effects on therapeutic ratio.
De Gersem WR; Derycke S; De Wagter C; De Neve WC
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):255-60. PubMed ID: 10758332
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of the delivered dose based on cone-beam CT and deformable image registration for non-small cell lung cancer treated with hypofractionated radiotherapy.
Wang B; Wang DQ; Lin MS; Lu SP; Zhang J; Chen L; Li QW; Cheng ZK; Liu FJ; Guo JY; Liu H; Qiu B
BMC Cancer; 2020 Nov; 20(1):1112. PubMed ID: 33198676
[TBL] [Abstract][Full Text] [Related]
19. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.
Murshed H; Liu HH; Liao Z; Barker JL; Wang X; Tucker SL; Chandra A; Guerrero T; Stevens C; Chang JY; Jeter M; Cox JD; Komaki R; Mohan R
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1258-67. PubMed ID: 15001271
[TBL] [Abstract][Full Text] [Related]
20. The impact of induction chemotherapy on the dosimetric parameters of subsequent radiotherapy: an investigation of 30 consecutive patients with locally-advanced non-small cell lung cancer and modern radiation planning techniques.
Grant JD; Sobremonte A; Hillebrandt E; Allen PK; Gomez DR
Radiat Oncol; 2015 Jan; 10():32. PubMed ID: 25636372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]